Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells
about
Molecular physiology and genetics of Na+-independent SLC4 anion exchangersBile acids in treatment of ocular diseaseRecent advances in understanding and managing cholestasisUp-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis.Metabolomics Coupled with Multivariate Data and Pathway Analysis on Potential Biomarkers in Cholestasis and Intervention Effect of Paeonia lactiflora Pall.Clinical application of transcriptional activators of bile salt transporters.Large dosage of chishao in formulae for cholestatic hepatitis: a systematic review and meta-analysis.Advances in pharmacotherapy for primary biliary cirrhosis.Nuclear receptors as drug targets in cholestatic liver diseases.Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ outputNuclear receptors as therapeutic targets in cholestatic liver diseases.Role of AE2 for pHi regulation in biliary epithelial cells.Bile acid transporters and regulatory nuclear receptors in the liver and beyondPrimary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics.Old and rising stars in the lymphoid liverMiRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation.Update on pharmacotherapies for cholestatic liver disease.
P2860
Q24642152-25B6186A-547F-422D-A6B4-9233B00A2039Q24653326-ADB4603B-08A6-496D-94EA-66513677A178Q26748537-4F7F7B2A-9A50-4C1C-8DDF-9A4A69021148Q30522942-B3C7728C-D20F-47EF-A40B-C72826635E0CQ31044588-00FC9137-A479-4A18-A973-134198618430Q33709930-D31634BB-DD0C-4325-84EB-D295E0B8C03BQ33766461-63FEA3BC-3118-408B-873B-70511BBAC1E9Q36116022-71C4F7EF-413C-4B17-8444-7DFFC9091302Q36786270-4388E3C9-D42A-43C1-A528-B500E90C89BCQ37096585-2A9A1429-BA08-4280-A434-A48839B859B7Q37230857-EA9F89EF-8AB3-4AC6-8112-3B828A1C8696Q37488881-0213ABE7-B2BE-4DDA-86AA-4311350F4949Q38033967-F973059F-0A24-455A-9F8D-07C3980C81EBQ39047912-664D784E-80BA-4FEF-B8AB-0F36B70BBB8CQ42578244-168B8150-9B0D-4B57-93D7-892C63890D1DQ47784988-F434B4AC-0C52-4411-9C2E-B7A7F54D2518Q55333522-E857C643-EB52-4CDD-AD08-DCD606289744
P2860
Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Combination of ursodeoxycholic ...... promoter in human liver cells
@ast
Combination of ursodeoxycholic ...... promoter in human liver cells
@en
type
label
Combination of ursodeoxycholic ...... promoter in human liver cells
@ast
Combination of ursodeoxycholic ...... promoter in human liver cells
@en
prefLabel
Combination of ursodeoxycholic ...... promoter in human liver cells
@ast
Combination of ursodeoxycholic ...... promoter in human liver cells
@en
P2093
P2860
P356
P1476
Combination of ursodeoxycholic ...... promoter in human liver cells
@en
P2093
Isabel Hervias
Juan F Medina
Miriam Uriz
Ruth Joplin
P2860
P304
P356
10.1172/JCI33156
P407
P577
2008-02-01T00:00:00Z